John Sperzel is President, Chief Executive Officer and Chairman of the Board of Directors of T2 Biosystems, Inc. (TTOO). The company reported total compensation of $865,500 for fiscal year 2023.
| Salary | $575,000 |
|---|---|
| Bonus | $0 |
| Stock awards | $0 |
| Option awards | $0 |
| Non-equity incentive plan | $287,500 |
| Pension and non-qualified deferred compensation | $0 |
| All other compensation | $3,000 |
| Total | $865,500 |
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed, without adjustment.
Cited to the compensation disclosure T2 Biosystems, Inc. filed November 20, 2024, accession 0001193125-24-262554.
| Fiscal year | Role | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension / NQDC | All other | Total |
|---|---|---|---|---|---|---|---|---|---|
| FY2023 | President, Chief Executive Officer and Chairman of the Board of Directors | $575,000 | $0 | $0 | $0 | $287,500 | $0 | $3,000 | $865,500 |
| FY2022 | President, Chief Executive Officer and Chairman of the Board of Directors | $575,000 | $0 | $1,119,840 | $0 | $287,500 | $0 | $3,000 | $1,985,340 |
Totals as disclosed in each year's own compensation disclosure for T2 Biosystems, Inc..
| Named executive officer | Role | FY2023 total |
|---|---|---|
| John Sperzel this page | President, Chief Executive Officer and Chairman of the Board of Directors | $865,500 |
| Michael Gibbs | SVP and General Counsel | $622,600 |
| John Sprague | Chief Financial Officer | $581,000 |
The company's named executive officers for fiscal year 2023, and what it reported for each. See the full T2 Biosystems, Inc. compensation brief.
John Sperzel's compensation sits inside T2 Biosystems, Inc.'s full executive and board picture — the peer group, pay against peers, incentive design and the board itself.